TULSA, Okla., Feb. 25, 2021 (GLOBE NEWSWIRE) -- AAON, INC. (NASDAQ-AAON), today announced its results for the fourth quarter of 2020. Financial Highlights: Three Months Ended December 31, % Years Ending December 31, % 2020 2019 Change …
– Strong Commercial Execution for Second Full Year of TIBSOVO® with Fourth Quarter Net Revenue of $39.1M and $121.1M for Full Year 2020 – – Sale of Oncology Portfolio Expected to Close Around March 31 Subject to March 25 Shareholder Vote, Allowing Agios to …
CICERO, Ill., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ: BWEN), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced results for the fourth quarter and full-year 2020. FULL-YEAR 2020 …
Record Annual Revenue of $113.6 Million and Operating Cash Flow of $8.8 Million Quarterly Revenue Up 7% Sequentially to $29.4 Million, Driving 4% Sequential Increase in High Margin, Recurring and Services Revenue to $17.3 Million WOODCLIFF LAKE, N.J., Feb. …
TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- RATESDOTCA, Canada's leading rate comparison website, is pleased to announce Jameson Berkow joined the company as Managing Editor on February 22, 2021. In this role, Berkow will oversee the production of …
WATERTOWN, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today …
WATERTOWN, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Company …
Full year 2020 TYMLOS® U.S. net sales of $208 million was year-over-year growth of 20% Q4 2020 TYMLOS U.S. net sales: $60 million was 8% growth vs. Q4 2019 and 19% growth vs. Q3 2020 New patient starts: increased by 26% in Q4 2020 vs. Q3 2020 ATOM, …
Enrollment in the Phase 1 AdCOVID™ Clinical Trial has Commenced Development of AdCOVID Vectors Targeting Emerging Variants of the SARS-CoV-2 Virus has Begun ALT-801 is Progressing Through the Phase 1 Clinical Trial Solidly Capitalized to Advance Pipeline …
BANNOCKBURN, Ill., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today reported results for the fourth quarter ended December 31, 2020. Revenues for the fourth quarter were $655.9 million, a decrease of 18.0% compared to $799.9 million …
SEATTLE, Feb. 25, 2021 (GLOBE NEWSWIRE) -- McObject®, developer of the eXtremeDB® embedded database system, is celebrating 20 years and over 30,000,000 deployments world-wide this year. As the first embedded database management system created specifically …
MIAMI, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings”, “Norwegian” or the “Company”) today reported financial results for the fourth quarter and full …
INDIANAPOLIS, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today that it has appointed Michael-Bryant Hicks as Executive Vice President, General Counsel, and Corporate Secretary. Hicks will be based in …
LATHAM, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a leading provider of hydrogen engines and fueling solutions enabling e-mobility, has announced today its 2020 fourth quarter and year end results. The quarterly shareholder …
Strengthened Leadership by Appointing James (Jim) C. Mullen as President and Chief Executive Officer, and Lisa A. Michaels, M.D., as Chief Medical Officer Appointed Meeta Chatterjee, Ph.D., to Board of Directors Initiated dosing of adult mid-dose cohort of …
EDISON, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos"), a leading provider of safe, scalable, efficient, and sustainable zinc-based energy storage systems, today announced financial results for the …
—ORLADEYO™ (berotralstat) now approved in U.S. and Japan; EU approval expected in Q2— —Dose-ranging trial of BCX9930 has fully enrolled 16 PNH patients; Data to be presented at R&D day March 22 — —Company adds $325 million in financing in Q4 2020; Year …
NEW YORK and SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) today announced a strategic collaboration with Tempus to leverage the company’s patient-derived organoid biological modeling platform to strengthen …
LAS VEGAS, Feb. 25, 2021 (GLOBE NEWSWIRE) -- NRT Technology, one of the largest and fastest growing Fin-Tech and Information Technology companies in the global gaming industry, has just announced a new strategic partnership with Sightline Payments, the …
– Acquisition of Oncoceutics Adds Late-Stage Precision Oncology Pipeline – – Recently Completed Financing Supports Broad Investment Across Pipeline – – Conference Call at 8:30 a.m. ET Today – DURHAM, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ …
06 days 20:21:48
